Advertisement

The Latest

Wausau, Wis.-based Aspirus Health has named Laurent Cauchi vice president and chief supply officer. Mr. Cauchi will lead systemwide supply chain operations, strategic sourcing, inventory management, value analysis, distribution and supplier partnership strategies, according to an Aug. 13 Aspirus Health…

The Illinois Critical Access Hospital Network has executed three grant agreements worth more than $50 million with the state to fund rural hospital technology, disease prevention and workforce initiatives. ICAHN signed the agreements with the Illinois Department of Healthcare and…

Chesterfield, Mo.-based Mercy reported a 22% reduction in flowsheet documentation time per shift after rolling out Microsoft’s Dragon Copilot AI assistant to nurses, according to a Microsoft customer story published Aug. 14. Mercy piloted the ambient AI tool in a…

Homestead (Fla.) Hospital, part of Coral Gables, Fla.-based Baptist Health South Florida, has named Amy Montes, PharmD, director of pharmacy, according to an Aug. 11 LinkedIn post. Dr. Montes has worked at Baptist Health since February 2017, according to her…

Debbie Cancilla has retired as executive vice president of data strategy and CIO of Philadelphia-based Temple University Health System. Vinay Bharel, senior vice president of information systems operations, now serves as interim CIO. Ms. Cancilla joined the 6-hospital academic system…

Texting has become one of the most reliable ways to reach patients, but hospitals can easily overuse this communication mode and risk losing the channel entirely, Penn Medicine researchers wrote in a June 29 viewpoint in JAMA Internal Medicine. Kimberly…

AdventHealth and Intermountain’s Denver-area joint venture is forging ahead and Wellstar completed its acquisition of a critical access hospital. Here are three hospital M&A moves Becker’s reported during the week of Aug. 10:  1. Altamonte Springs, Fla.-based AdventHealth and Salt…

The FDA has granted accelerated approval to Bristol Myers Squibb’s Zenbexus, the first FDA-approved cereblon E3 ligase modulator, or CELMoD, a new class of treatment for multiple myeloma. Zenbexus (iberdomide), in combination with daratumumab and hyaluronidase-fihj and dexamethasone, was approved…

Salt Lake City-based Intermountain Health is approaching behavioral health access challenges by first addressing one quality concern in particular: whether patients are actually getting better. That’s the premise behind the health system’s push to embed measurement-based care across its behavioral…

Advertisement